Sonnet BioTherapeutics (SONN) News Today → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free SONN Stock Alerts $1.62 -0.03 (-1.82%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29 at 2:48 AM | americanbankingnews.comSonnet BioTherapeutics' (SONN) "Buy" Rating Reaffirmed at Chardan CapitalMay 28 at 8:00 AM | globenewswire.comSonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual MeetingMay 22, 2024 | finanznachrichten.deSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Review of Strategic AlternativesMay 22, 2024 | finance.yahoo.comSonnet BioTherapeutics Announces Review of Strategic AlternativesMay 15, 2024 | investorplace.comSONN Stock Earnings: Sonnet BioTherapeutics Misses EPS for Q2 2024April 28, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM) and HCA Healthcare (HCA)April 17, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Genmab (GMAB)April 12, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS)March 11, 2024 | finance.yahoo.comSonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified ObjectiveMarch 1, 2024 | morningstar.comSonnet BioTherapeutics Holdings Inc Ordinary Shares SONNFebruary 29, 2024 | finanznachrichten.deSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy VolunteersFebruary 29, 2024 | msn.comSonnet BioTherapeutics Reported SON-1010 Phase I Trial Results: Demonstrates Safety, Efficacy in Melanoma Model, and Potential for Dose EscalationFebruary 17, 2024 | finance.yahoo.comSonnet BioTherapeutics Holdings First Quarter 2024 Earnings: Beats ExpectationsFebruary 14, 2024 | finance.yahoo.comSonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings UpdateFebruary 7, 2024 | msn.comNasdaq panel expected to decide on Yield10 listing within next monthJanuary 1, 2024 | markets.businessinsider.comBTIG Keeps Their Buy Rating on Sonnet BioTherapeutics Holdings (SONN)December 22, 2023 | msn.comSonnet BioTherapeutics files for $100M mixed shelfDecember 21, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor ImmunotherapyDecember 16, 2023 | markets.businessinsider.comBuy Rating Affirmed for Sonnet BioTherapeutics Amid Promising Oncology Trials and Financial FortitudeDecember 14, 2023 | finance.yahoo.comSonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial UpdateOctober 31, 2023 | finance.yahoo.comSonnet BioTherapeutics Provides Fiscal Year 2023 Business OverviewOctober 26, 2023 | benzinga.comWhat's Happening With Sonnet BioTherapeutics (SONN) Shares?October 25, 2023 | markets.businessinsider.comDow Falls Over 100 Points; Alphabet Shares Tumble After Q3 ResultsOctober 25, 2023 | msn.comSonnet BioTherapeutics down 32%, prices $4.55M stock offeringOctober 25, 2023 | benzinga.comWhy Sonnet BioTherapeutics (SONN) Stock Is Getting HammeredOctober 25, 2023 | marketwatch.comSonnet BioTherapeutics Shares Slide Premarket After Stock OfferingOctober 25, 2023 | msn.comWhy Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?October 25, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public OfferingOctober 17, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual MeetingOctober 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Ambrx Biopharma (AMAM) and Aldeyra Therapeutics (ALDX)September 20, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB TechnologySeptember 19, 2023 | msn.comSonnet BioTherapeutics regains listing complianceSeptember 19, 2023 | finance.yahoo.comSonnet BioTherapeutics Regains Nasdaq Minimum Bid Price ComplianceSeptember 1, 2023 | marketbeat.comTrading was temporarily halted for "SONN" at 10:09 AM with a stated reason of "LULD pause." Trading set to resume at 10:09 AM. September 1, 2023 | marketbeat.comTrading was temporarily halted for "SONN" at 09:09 AM with a stated reason of "LULD pause."August 31, 2023 | msn.comSonnet BioTherapeutics launches 1-for-22 reverse stock splitAugust 31, 2023 | benzinga.comWhy Sonnet BioTherapeutics Stock (SONN) Is Getting ObliteratedAugust 31, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces 1-for-22 Reverse Stock SplitAugust 17, 2023 | markets.businessinsider.comChardan Capital Keeps Their Buy Rating on Sonnet BioTherapeutics Holdings (SONN)August 16, 2023 | marketwatch.comSonnet BioTherapeutics Shares Rise After FDA Approves Drug TrialAugust 16, 2023 | finance.yahoo.comSonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the USAugust 14, 2023 | finanznachrichten.deSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings UpdateAugust 14, 2023 | finance.yahoo.comSonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings UpdateJuly 31, 2023 | investorplace.comWhy Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?July 31, 2023 | finanznachrichten.deSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology ConferenceJuly 31, 2023 | finance.yahoo.comSonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology ConferenceJuly 3, 2023 | finance.yahoo.comBeat the Market the Zacks Way: Vertiv, Costco, Sonnet BioTherapeutics in FocusJune 29, 2023 | seekingalpha.comSonnet BioTherapeutics stock plummets 20% on $2.25M registered direct offeringJune 28, 2023 | msn.comWhy Sonnet BioTherapeutics (SONN) Stock Is NosedivingJune 28, 2023 | finanznachrichten.deSonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement Get Sonnet BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here SONN Media Mentions By Week SONN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SONN News Sentiment▼0.620.79▲Average Medical News Sentiment SONN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SONN Articles This Week▼71▲SONN Articles Average Week Get Sonnet BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cingulate News Today NovaBay Pharmaceuticals News Today China Pharma News Today Genprex News Today Clever Leaves News Today Artelo Biosciences News Today Bright Minds Biosciences News Today Processa Pharmaceuticals News Today Lipella Pharmaceuticals News Today Biofrontera News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SONN) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
